Three commercially available preparations of human nnmunoglobuhn for intravenous use (IVIgG), namely Gatmmune N, Sandoglobuhn and Intraglobm F, were tested for their ability to modulate human neutrophfl function in ~ltro IVIgG consistently stimulated the neutrophfl respiratory burst at concentrations of 0 5 to I mg/ml, concentrations readily achieved m ,n~ o by moderate-dose therapy Superoxlde (O z ) release was increased by 3 5~4 5 nmol per 5 x 105 cells at these concentrations of IVlgG, and H202 production increased m a dose-dependent fashion up to 8 mg/ml IVIgG Lumlnol-dependent chemiluminescence (CL) was also directly stimulated by IVIgG In addition, the effects of both soluble and pamculate btlmulators (N-formyl-methlonyMeucyl-phenylalanme, phorbol myrlstate acetate and opsomzed zymosan) on the neutrophll respiratory burst were enhanced by IVIgG In a filter assay of neutrophll mlgrahon, using a modified Boyden chamber, no consistent effect on neutrophll Iocomohon or chemotax~s could be demonstrated The effect of IVIgG on neutrophfl metabohsm may contribute to its beneficial therapeuhc effect m severe, hfe-threatenlng infections
Introduction
The use of intravenous immunoglobuhn (IVIgG) is established in the treatment of idiopathic thrombocytopenic purpura (ITP), it may be utlhzed as firstline therapy in children and as second-hne therapy m adults who are refractory to steroids (Imbach et al, 1981 : Newland, 1987 . It is also effectwe m the treatment of alloimmune neonatal neutropenla (Barundun et al., 1982) and post-transfusion purpura (Mueller-Eckhardt et al., 1983) . Regular infusion of IVIgG m primary hypogammaglobuhnemla and related disorders may, in fact, be superior to conventional replacement regimens using intramuscular IgG (McClelland and Yap, 1987) . It is of value m the treatment of infants with AIDS (Calvelh and Rubmsteln, 1986) , however, ~ts place in the treatment of severe refections m the lmmuno-comproraised host has not yet been clearly defined (Yap, 1987) The mechanism by which IVIgG decreases cell destructmn m the immune cytopenias has been a subject of speculation (Imbach, 1983 , Salama et al., 1983 ) Jungl et al. (1986 demonstrated that IVIgG preparations could interact wnh Fc receptors of hu-man monocytes and macrophages to lnh~blt the phagocytosis of IgG-sensitized erythrocytes Highdose IVIgG may also modulate the immune response by reducing the lymphocyte CD4 CD8 ratio and by reducing B-cell lmmunoglobuhn synthesis (Tsubaklo et al., 1983 , Dammacco et al, 1986 Since the neutrophll is central to the acute inflammatory response and in defence against most bacterial pathogens, it is important to know whether neutrophil functions are m any way modulated by IVIgG in the concentrations achieved by high-dose therapy In the present study we set out to examine the effect of three commercially available IVlgG preparations on neutrophll function m vitro, re, superoxlde Ion (O2-) release, H202 production, chemiluminescence (CL) and chemotaxis
Materials and Methods

Intravenous mummoglohulm
Three IVIgG preparations were used in this study Intraglobln F (Blotest Pharma Gmbh, Drelelch, F R G, lot 412087), Sandoglobuhn (Sandoz Pharmaceuticals Corp., East Haven, N J, lot 7 369.157 0) and Gamlmune N (Cutter Biological, Berkeley, CA, lot 40C13A). Sandoglobuhn is prepared by the method developed by the Swiss Red Cross, Cohn effluent III IgG from pooled human plasma is treated at low pH (4-4.5) in the presence of a very, low concentraUon of porcine pepsin Gamlmune ~s made by essentially the same method except that pepsin is omitted. In contrast, Intraglobln F ~s chemically modified, Cohn effluent III IgG is treated with fi-proplolactone These preparations all contain >98% IgG, Gamlmune N contains neghglble amounts of aggregates, dimers and fragments Sandoglobuhn contains < 1% aggregates, 9 10% dlmers and no detectable fragments Intraglobin F contains no detectable aggregates, 3 4% dimers and 9 10% fragments (Lundblad et al, 1987) Intraglobln F and Gamlmune N are supphed as solutions of 50 mg protein/ml. For convenience these were diluted to 40 mg/ml with Hank's balanced salt solution (HBSS), pH 7.4, so that when further diluted 1/'10 under experimental conditions a final concentration of 4 mg/ml was obtained Sandoglobuhn was supphed freeze-dried, and was reconstituted m HBSS at a concentrauon of 40 rag,' ml Doubling dilutions were made in HBSS for dose-response experiments Concentrations of IVIgG used in ~ltro ranged from 0 25 mg:ml to 8 mg/ml. High-dose IVIgG therapy' ~s known to achieve serum concentrations of the order of 8 rag/ ml (Pirofsky, 1987) Each IVIgG contains career sugar as a stabfllzcr and it has been shown previously that both maltose and glucose inhibit the stimulatory effect of IVIgG on neutrophlls, measured by O2 release (Koch et al, 1984) Therefore, in all experiments the eqmvalent concentratmn of the sugar was added to control tubes which did not contain IVIgG. lntraglobm F, 40 mg/ml, contained glucose 18 mg/ml m excess of glucose in HBSS Sandoglobuhn, 40 mg/ml, contamed sucrose 67 mg/ml. Gamlmune N, 40 mg/ml, contained maltose 80 mg/ml The control sugar concentrations are referred to below as "career-sugar'.
pH e/lect o/II'IgG
When added to HBSS Intraglobln F at 8 mg and 4 mg/ml reduced the pH b}¢ 0.1 and 0 05 respectively. Sandoglobuhn reduced the pH by 0 02 and 0 01 In contrast, Gamlmune N reduced the pH by 0 8 at 8 mg/ml and by 0 3 at 4 mg/ml. Because of this effect, the highest final concentration of Gamlmune N used experimentally was 4 mg/ml A maximum drop in pH from 7 4 to 7 1 was considered acceptable in the assay systems of PMN funcuon
Cell stimulants
Particulate and soluble stimulants of the neutrophll respiratory burst were employed to determine whether the stimulated response was too&fled by' the presence of IVIgG Opsonlzed zymosan (OZ) was used as the particulate stimulant. Zymosan (Sigma Chemical Co., St Louis, MO) was boiled m normal saline for 1 h, washed once m HBSS and resuspended in HBSS at 50 mg/ml as a stock suspension which was stored at 4°C Zymosan stock was opsonlzed by incubation with an equal volume of fresh normal human serum at 37°C for 30 tnln After washing twice in HBSS it was resuspended m HBSS at 10 mg/ml and stored at 4°C. OZ was used within one week of preparation Phorbol myrlstate acetate (PMA, LC Services Corp., Woburn, MA) and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP, Sigma Chemical Co., St. Louis, MO) were the soluble stimulants employed
Chemoattractant
Zymosan-activated serum (ZAS) was the standard chemoattractant. Fresh human serum was incubated with washed Zymosan (5 mg Zymosan to 1 ml of serum) at 37°C for 30 mm The Zymosan was spun down and the serum plpetted off. ZAS was aliquotted and stored at -70°C. A 1/7 dilution of ZAS was used in all experiments
Use o[ cell stimulants in resptratoo' burst assays
OZ was added to the cells to a final concentration of 1 mg OZ per 5 × 105 cells PMA was used at a final concentration of 10 ng/ml and FMLP at 10 -6 M. In each case stock solution was diluted m HBSS to an appropriate dilution and 0.1 ml of this dilution was added to 0 9 ml of the cell reaction mixture. The modifying effect of IVlgG on the stimulation of the respiratory burst was also examined by adding 0.1 ml of the appropriate dilution of IVIgG immediately before the stimulant.
Separation of neutrophtls Jrom blood
Human blood was taken from healthy volunteers and anticoagulated with preservative-free heparin (Elkms-Sinn Inc, Cherry Hill, NJ) at 10 U/ml of blood Neutrophlls were separated by buoyant denslty centnfugatlon over Flcoll/Hypaque according to the method of Ferrante and Thong (1980) . Seven ml of blood were layered over 4 ml of Neutrophil Isolation Medium (Los Alamos Dmgnostlcs, Los Alamos, NM) m a 15 ml tube and centrifuged at 400 × g for 30 mm. After discarding the plasma and mononuclear cell/platelet layers, the neutrophil layer was carefully separated using a Pasteur pipette and immediately diluted in HBSS. The neutrophfls together with the contaminating erythrocytes were spun down at 500 × g for 5 mln, and the erythrocytes were lysed by 20 s exposure to distilled H20, 99 two cycles. Leukocytes were then washed once m HBSS, resuspended m HBSS and kept on ice until tested for respiratory burst actwity or chemotax~s. The final cell preparation contained 88 99% neutrophfls (mean, 95 5%) and viability was greater than 99% by trypan blue exclusion.
Superoxtde release assay
Release of superoxlde 1on (02) was measured by the superox~de dlsmutase (SOD) mhlbltable reduction of cytochrome c as described by McCord and Fridovlch (1969) The test was performed m 5 ml polypropylene tubes (Sarstedt, Numbrecht, W Germany). Neutrophfls were suspended in HBSS to a concentration of 1 × 10 ° cells/ml: 0.5 ml of cell suspension was added to each tube together with 1 mg/ml of ferricytochrome c (Sigma Type III, Sigma Chemical Co., St. Louis, MO). Control tubes contamed 0.023 mg/ml of SOD (Diagnostic Data, Mountamview, CA). Volumes were adjusted to 1 ml with HBSS. Tubes were incubated in a shaking water bath for 20 mm at 37°C and the reaction was stopped in the tubes without SOD by adding 0.023 mg of SOD m 100/A. The volumes m all tubes were then made up to 1.8 ml with HBSS and the cells were spun down at 1500 x g for 5 mm at 4°C Finally, the reduction of cytochrome c was measured by reading the absorbance of the supernatant at 550 nm in a spectrophotometer, taking the SODcontaining supernatant as the reference. The difference between the -SOD and + SOD tubes was calculated. Using an extinction coefficient of 18 5 cm-1 mM 1 for cytochrome c (reduced-oxidized) at 550 rim, the difference in absorbance was multiplied by 97 to obtain nm O2-/ml (Margoliash and Frohwlrt, 1959) . Addition of IVIgG and stimulants was carried out as described above.
Intracelhdar H202 production
The assay used was that originally described by Keston and Brandt (1965) and adapted for flow cytometry by Bass et al. (1983) . It depends on the use of the nonfluorescent hydrophobic compound 2',7'-dlchlorofluorescln dlacetate (DCFH-DA) which penetrates the cell membrane and is trapped lntracellularly by hydrolytic deacetylation to 2',7'-dl-chlorofluorescln (DCFH) This compound is readdy oxidized by H202, in the presence of peroxldase, to the fuorescent compound 2',7'-dmhlorofluoresceln (DCF). The conversion to DCF can be measured by flow cytometry, thus giving a quantitative assessment of H,O2 productmn within the cells Freshly isolated neutrophds were suspended m PBS containing 0 1% gelatin, pH 7 4, at 5 5 × 10 s cells,' ml, DCFH-DA (Molecular Probes, Eugene, OR) was added to give a concentration of 20 t~M and the cells were Incubated at 37°C for 15 min To each 5 ml polystyrene tube was added 0 45 ml of the DCFH-DA labelled cell suspension and after addition of 0 05 ml of IVIgG and/or cell stimulant the tubes were incubated at 37°C for 45 mln m a water bath. Three thousand cells were examined in a flow cytometer (EPICS-541, EPICS DlvlSlOm Coulter Electronics, Hialeah, FL) equipped with an argon laser set at an excitation wavelength of 488 nm Green fluorescent emission (510-550 nm) was recorded Fluorescing neutrophlls were separated from other contaminating cell types by electronic gating Cell fluorescence was expressed as the mean channel number after correction for the gain setting of the photomultlpher tube Dose responses to IVlgG preparations were done w~th single samples In experiments to examine the modulating influence of IVlgG on the effect of cell stimulants, samples were run m triplicate C/WlT~IIhlIHlllCSCUII¢'¢ (IAS~IV The Lummol-amphfied chemdummescent response (CL) of neutrophlls was assayed essentially as described by Robinson and Penny (1982) Freshly, isolated neutrophlls were suspended in HBSS at 2 × 105 cells.,"ml 0 5 ml ahquots of the cell suspension were added to glass scintillation vials, followed by 0 05 ml of a 10 _3 M stock solution of 5-ammo-2,3-dlhydro-l,4-phthalazmedmne (Lumlnol, Eastman Kodak, Rochester, NY) and HBBS so that the final reaction volume was 1 ml IVIgG and/or stimulants were added and the vials were immediately placed in a hqmd sclntdlatlon counter (Beckman LS 5801, Beckman Instruments, Fullertom, CA) set for single-photon counting Chemiluminescence was measured at ambient temperature (23°C). Samples were recycled for up to 1 h and CL was recorded as peak counts per minute (cpm). All CL experiments were performed using single samples because of the need to recycle vials at short time intervals to measure the peak CL response
Chemotaxls assay
This was performed by measuring the distance of cell migration through a 5 #m-pore-size nitrocellulose filter m a modified Boyden chamber Chemoattractant (ZAS) or HBSS was plpetted into the lower chambers. The filters (Schlelcher & Schuell, Keene, NH) were saturated in HBSS containing 0.1% BSA and clamped between the lower and upper chambers Neutrophlls suspended in HBSS with 0 1% BSA (1 5 × 1() ~ cells,,'ml) were dispensed into the upper chambers and cell migration was allowed to proceed at 37°C for 50 rain, after which the filters were stained w~th haematoxyhn The &stance of cell migration was measured by the leading-front method of Zlgmond and Hlrsch (1972) using a standard mmroscope micrometer A reading was made in five different fields of each filter and the mean distance migrated was calculated m micrometers All assays were run in duplicate. The effect of IVIgG on chemoklnesls or ZAS-lnduced chemotaxis was examined by adding IVIgG or carrier-sugar to the cell suspension immediately, before dispensing cells into the chambers
Staltslu'al analysts
The significance of differences between test groups and controls was calculated using the one-tailed t test of Student
Results
Effect o/ IVIgG on 0 2 -release and H20E ,~em, ratum
The effect of the three IVIgG preparations on 02 release by human neutrophlls m vitro was tested over a range of concentrations from 0 13 mg/ml to 8 mg/ml The results are summarized in Table I SUmulatlon at levels of stahstlcal slgmficance was seen m the concentranon range 1-2 mg/ml. Sandoglobuhn had the greatest stlmulatory effect, and the max> mum increment of 4.7 nm was seen at a dose of 1 mg/ml. Intraglobm F was lnhlbltory at the highest concentratmn used (8 mg/ml) To exclude the possibility that this sUmulatmn of O2-release was simply due to protein, human serum albumin (HSA) was added to neutrophils at concentrations of 2 and 4 mg/ml and O2-release was compared with control cells to which no HSA was added HSA mhlblted O2-release at these concentratlons
In contrast to the effect on O2-release, lntraglobin F and Sandoglobuhn resulted in increased H202 production by neutrophfls in a dose-dependent fashion up to the highest concentration (8 mg/ ml) Peak stimulation by Gamlmune N was seen at l mg/ml (Fig. 1.) Further experiments were performed to determine whether IVIgG had any enhancing or additive effect on stimulated 02 release and H202 producnon when OZ, PMA and FMLP were used a stimulants. The stimulants were added to the cells immediately after the IVIgG (or control sugar solution). The results of these experiments are summanzed in Table II Sandoglobuhn enhanced 
Effect of lVIgG on neutrophd chemthml&escence
Both Intraglobm F and Gamimune N stimulated Luminol-amphfied chemiluminescence at concentrattons in the region of 0.5-1 mg/ml Stlmulatton indices (SI = peak stimulated cpm • peak control cpm) were in the range 1.5 to 2 3. Sandoglobuhn, on the other hand, stimulated only at the highest dose (8 mg/ml), SI 2 7. Assays were carried out to determine the effect of the presence of IVIgG on CL stimulated by OZ partlcles. IVIgG (or control sugar solution) was added to the cells immediately before the OZ. Intraglobln had no additive effect and was inhibitory at 4 and 8 mg/ml Sandoglobuhn and Gamimune N both showed a dose-dependent enhancing effect, maximal at 1 mg/ml. The results using Gamimune N are Fig 2 Enhancing effect of Sandoglobuhn 0 2 mg/ml on neutrophil chemdummescence response to opsonlzed zymosan Controls contained sucrose 1 7 mg/ml in place of IVIgG In order to recycle wals as rapidly as possible tn the counter, single samples were assayed phIls was decreased by most concentrations of Intraglobin and Sandoglobuhn, and in the presence of Gamlmune N migration was increased, these differences &d not reach levels of statistxcal s~gnificance (Table IV) .
Discussion
Various mechanisms have been proposed to explain how IVIgG reduces cell destruction in the immune cytopenias (Imbach, 1983) . The most popular theory is that IVIgG interacts with Fc receptors of mononuclear phagocytes, thereby inhibiting the phagocytosis of cells (red cells, platelets or neutrophils) opsonlzed by autoantibody (or alloantibody). There ts in vitro experimental evidence to support this concept (Jungi et al., 1986 ). An equally attractive hypothesis is that infused immunoglobuhn binds to red blood cells which are then preferentially sequestered by macrophages; support for this mechanism is provided by the chnlcal findlng that the injection of anti-Rho(D) ts effective an treating ITP (Salama et al., 1983 , Baghn et al., 1986 . In addiUon to the effect of macrophage blockade, IVIgG may modulate the immune response by altering the proportions of T-cell subsets or by nonspecific inhibition of B-cell responsiveness (Tsublaklo et al., 1983; Dammacco et al., 1986; Stohl, 1986) . The beneficial effect of IgG replacement therapy in hypogammaglobulinemla is presumably due largely to passive immunization with preformed specific antibodies; such antibodies against a w~de range of bacterial and vtral pathogens can readily be demonstrated in human IgG for both IV and IM use (Yap, 1987) . However, experimental and clinical evidence indicates that IVIgG may interact with macrophage Fc receptors and, in other unspecified ways, modulate the immune response, as already discussed This raises the possibility that ~t may also mfluence neutrophll function. Koch et al. (1984) showed that IVIgG can stimulate neutrophil 02-release and chemiluminescence in wtro; the present study was designed to further mvestigate this effect. The neutrophll respiratory burst was examined usmg three assays; O 2 -release, H202 production and Lummol-dependent chemiluminescence (CL). The CL response of activated neutrophlls correlates well with metabohc activation (Allen et al, 1972) , but there has been considerable controversy as to what is the chief oxidizing species measured in Lumlnoldependent CL. De Chatelet and Shirley (1981) have argued that it is largely due to HOCI which diffuses extracellularly and reacts with Luminol to form amlnophthalate ions and hght generation.
In all three types of assay our results indicated that IVIgG can directly stimulate the neutrophll respiratory burst. The maximum increase in O2-release was of the order of 3.5-4.55 nmol (per 5 × 105 cells) and this was achieved by concentrations of 0.5-1 mg/ml IVIgG, concentrations which are readfly achieved in moderate-dose IVIgG therapy. High-dose therapy can achieve serum concentrations of the order of 8 mg/ml (Pirofsky, 1987) . In the case of H202 production, the stlmulatory effect on H202 was more clearly dose-dependent, and for two IVIgG preparations it appeared that the maximal H202 response was not reached in the range of concentrations used. The sttmulatory effects of OZ, PMA and FMLP were enhanced by IVIgG and this enhancing effect was more clearly seen in the H202 assay.
CL responses also indicated that IVIgG can directly stimulate neutrophils, as well as being able to enhance the metabolic response following ingestion of OZ.
There are few published reports on the effects of IVlgG on neutrophlls, either m VlVO or in vitro. Koch et al (1984) , using a blood leukocyte preparation conslstmg of both neutrophils and mononuclear cells, demonstrated that the neutrophfl respiratory burst was stimulated in vitro by IVlgG, The mammal increases in 02-release, 5 nmol per 10 ~' cells, was quite consistent with our own findmgs. Reddet al (1988) reported that human IVIgG reduced the severity of neutropenla in newborn rats after lntrapulmomc mJecnon of group B streptococci This was thought to be due to increased release of neutrophlls from the marrow and egress from the blood mto infected tissue IVIgG did not affect the production of neutrophfls in vitro or in VlVO
Of the three IVIgG preparatmns used m the present study, Intraglobln F (Blotest) has the highest content of dlmers and aggregates (Lundblad et al, 1987) . If the observed stimulation of neutrophfls was initiated by the mteraction of aggregated IgG with Fc receptors, we would have expected Intraglobln F to give consistently higher levels of stimulation This was not observed Monomerlc IgG is known to attach to Fc receptors of human monocytes (Kurlander, 1980) and, in the same way, must be able to bmd to Fc receptors of neutrophils. The stimulating effect of IVIgG on neutrophfl metabohsm could not be reproduced by another serum protem (HSA), suggesting that Fc receptor monomerlc IgG interaction may be the lnltlatmg event There is no doubt that the benefit of IVIgG therapy in hypogammaglobuhnemla, and m severe infection in the tmmunocompromtsed host, is primarily due to the passive provision of preformed antibodies. However, the findings of this study suggest that host defence may benefit secondarily from the direct stimulation of neutrophll metabohsm by IVIgG
